...
首页> 外文期刊>Transplantation Proceedings >Tigecycline for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections After Liver Transplantation in the Intensive Care Unit: A 3-Year Study
【24h】

Tigecycline for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections After Liver Transplantation in the Intensive Care Unit: A 3-Year Study

机译:替加环素治疗重症监护病房肝移植后耐碳青霉烯类抗肺炎克雷伯菌的感染

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background. This 3-year prospective, observational, single-center study was undertaken to describe prescription, microbiology findings, tolerance, and efficacy of tigecycline for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections after liver transplantation in the intensive care unit (ICU).
机译:背景。这项为期3年的前瞻性,观察性,单中心研究旨在描述在加护病房(ICU)肝移植后替加环素对耐碳青霉烯耐药性肺炎克雷伯菌(KRKB)感染的处方,微生物学发现,耐受性和疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号